Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
This issue covers a broad range of topics: Original research includes a nationwide Swedish study on antithrombotic strategies in patients with MI and atrial fibrillation, a win ratio re-analysis of the ADVANCE trial in type 2 diabetes, real-world evidence on SGLT2 inhibitors and sacubitril/valsartan in heart failure, a comparison of eplerenone versus spironolactone in HFrEF, and a retrospective cohort study on SSRI use and bleeding risk in patients on dual antiplatelet therapy after PCI
Expert-led, evidence-based
Another tactic is exposing yourself to the daily sunset and ensuring that you can observe the natural colour changes in the sky, from blue to red to black
Semaglutide resulted in 7.9 to 16 percent greater reduction in body weight compared to the other drugs, for which the range was 5.0 to 9.9 percent
References We invite you to comment on our Facebook page
Similar content being viewed by others Introduction Down syndrome (DS) is the chromosome abnormality defined by an extra copy of chromosome 21
US$ 28.55
US$ 25.60
US$ 24.90
US$ 21.69
US$ 26.46
US$ 20.30
